Home › Compare › ACORQ vs FCPT

ACORQ vs FCPT: Dividend Comparison 2026

ACORQ yields 20000.00% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACORQ wins by $52481917574412746752.00M in total portfolio value
10 years
ACORQ
ACORQ
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full ACORQ calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — ACORQ vs FCPT

📍 ACORQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACORQFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACORQ + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ACORQ pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACORQ
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, ACORQ beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACORQ + FCPT for your $10,000?

ACORQ: 50%FCPT: 50%
100% FCPT50/50100% ACORQ
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

ACORQ
No analyst data
Altman Z
-33.0
Piotroski
4/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACORQ buys
0
FCPT buys
0
No recent congressional trades found for ACORQ or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACORQFCPT
Forward yield20000.00% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$52481917574412746752.00M ✓$49.1K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$5,775.28
Total dividends collected$52448189483771600896.00M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ACORQ vs FCPT ($10,000, DRIP)

YearACORQ PortfolioACORQ Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$2,010,700$2,000,000.00$11,401$700.92+$2.00M → ACORQ
2$377,983,225$375,831,775.70$13,064$864.84+$377.97M → ACORQ
3$66,433,479,469$66,029,037,418.28$15,051$1,072.48+$66433.46M → ACORQ
4$10,916,985,471,987$10,845,901,648,955.73$17,442$1,337.22+$10916985.45M → ACORQ
5$1,677,384,363,769,318$1,665,703,189,314,291.80$20,340$1,677.08+$1677384363.75M → ACORQ
6$240,985,175,079,139,100$239,190,373,809,905,920.00$23,880$2,116.57+$240985175079.12M → ACORQ
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$28,241$2,689.36+$32373573631143.66M → ACORQ
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$33,660$3,442.07+$4066766648320630.00M → ACORQ
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$40,456$4,439.95+$477730483406513344.00M → ACORQ
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$49,063$5,775.28+$52481917574412746752.00M → ACORQ

ACORQ vs FCPT: Complete Analysis 2026

ACORQ — Stock

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York. On April 1, 2024, Acorda Therapeutics, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Full ACORQ Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this ACORQ vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACORQ vs SCHDACORQ vs JEPIACORQ vs OACORQ vs KOACORQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.